These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 6852235)

  • 1. The recognition of a soluble cytochrome P450 in rat liver.
    Hasegawa T
    FEBS Lett; 1983 May; 155(2):257-62. PubMed ID: 6852235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spectral intermediates during the reduction of hepatic microsomal cytochrome P-450.
    Miyake Y; Takayama N
    J Biochem; 1976 May; 79(5):1077-87. PubMed ID: 956135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidase and oxygenase function of the microsomal cytochrome P450 monooxygenase system.
    Kuthan H; Ullrich V
    Eur J Biochem; 1982 Sep; 126(3):583-8. PubMed ID: 7140747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kupffer cell stimulation with Corynebacterium parvum reduces some cytochrome P450-dependent activities and diminishes acetaminophen and carbon tetrachloride-induced liver injury in the rat.
    Raiford DS; Thigpen MC
    Toxicol Appl Pharmacol; 1994 Nov; 129(1):36-45. PubMed ID: 7974494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlations between spin equilibrium shift, reduction rate, and N-demethylation activity in liver microsomal cytochrome P-450 and a series of benzphetamine analogues as substrates.
    Blanck J; Rein H; Sommer M; Ristau O; Smettan G; Ruckpaul K
    Biochem Pharmacol; 1983 Jun; 32(11):1683-8. PubMed ID: 6870907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Partial inhibition of hepatic microsomal aminopyrine N-demethylase by caffeine in partially purified cytochrome P450.
    Govindwar SP; Kachole MS; Pawar SS
    Biochim Biophys Acta; 1983 Mar; 756(2):191-5. PubMed ID: 6830852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nordihydroguaiaretic acid, an inhibitor of lipoxygenase, also inhibits cytochrome P-450-mediated monooxygenase activity in rat epidermal and hepatic microsomes.
    Agarwal R; Wang ZY; Bik DP; Mukhtar H
    Drug Metab Dispos; 1991; 19(3):620-4. PubMed ID: 1680628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of human liver cytochrome P450 IIIA4 in yeast. A functional model for the hepatic enzyme.
    Renaud JP; Cullin C; Pompon D; Beaune P; Mansuy D
    Eur J Biochem; 1990 Dec; 194(3):889-96. PubMed ID: 2269307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A gel-electrophoretically homogeneous preparation of cytochrome P-450 from liver microsomes of phenobarbital-pretreated rabbits.
    Imai Y; Sato R
    Biochem Biophys Res Commun; 1974 Sep; 60(1):8-14. PubMed ID: 4472879
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of glucose administration on various rat hepatic constituents and on the spectral binding of hexobarbital and methadone to rat hepatic cytochrome P450.
    Buchholz J; Strother A; Fraser IM
    Pharmacology; 1989; 38(2):129-36. PubMed ID: 2727049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of renal cytochrome P-450 in hepatic microsomes of diabetic rats.
    Imaoka S; Shimojo N; Funae Y
    Biochem Biophys Res Commun; 1988 Apr; 152(2):680-7. PubMed ID: 3365247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple forms of hepatic cytochrome P-450. Purification, characterisation and comparison of a novel clofibrate-induced isozyme with other major forms of cytochrome P-450.
    Tamburini PP; Masson HA; Bains SK; Makowski RJ; Morris B; Gibson GG
    Eur J Biochem; 1984 Mar; 139(2):235-46. PubMed ID: 6698012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microsomal oxidation of N,N-diethylformamide and its effect on P450-dependent monooxygenases in rat liver.
    Amato G; Longo V; Mazzaccaro A; Gervasi PG
    Chem Res Toxicol; 1996; 9(5):882-90. PubMed ID: 8828925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding of thiols to microsomal cytochrome P-450.
    Nastainczyk W; Ruf HH; Ullrich V
    Chem Biol Interact; 1976 Aug; 14(3-4):251-63. PubMed ID: 182393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The nature of the "455 nm absorbing complex" formed during the cytochrome P450 dependent oxidative metabolism of amphetamine.
    Mansuy D; Beaune P; Chottard JC; Bartoli JF; Gans P
    Biochem Pharmacol; 1976 Mar; 25(5):609-12. PubMed ID: 942497
    [No Abstract]   [Full Text] [Related]  

  • 16. Characterization of a rat lung microsomal fraction obtained by sepharose 2B ultrafiltration.
    Capdevila J; Jakobsson SW; Jernström B; Helia O; Orrenius S
    Cancer Res; 1975 Oct; 35(10):2820-9. PubMed ID: 808269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reductive metabolism and protein binding of chromium(VI) by P450 protein enzymes.
    Mikalsen A; Alexander J; Wallin H; Ingelman-Sundberg M; Andersen RA
    Carcinogenesis; 1991 May; 12(5):825-31. PubMed ID: 1903091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of acute and repeated chlordimeform treatment on rat hepatic microsomal drug metabolizing enzymes.
    Budris DM; Yim GK; Schnell RC
    J Environ Pathol Toxicol Oncol; 1984 Jul; 5(4-5):175-82. PubMed ID: 6440975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N,N',N''-triethylenethiophosphoramide (thio-TEPA) oxygenation by constitutive hepatic P450 enzymes and modulation of drug metabolism and clearance in vivo by P450-inducing agents.
    Ng SF; Waxman DJ
    Cancer Res; 1991 May; 51(9):2340-5. PubMed ID: 1707751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Constitutive testosterone 6 beta-hydroxylase in rat liver.
    Imaoka S; Terano Y; Funae Y
    J Biochem; 1988 Sep; 104(3):481-7. PubMed ID: 3240989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.